Volcanoes are erupting in The Philippines, but on-fire Australia received some welcome rain. The Iran war cries have been called off and The Donald’s military powers are about to be hamstrung by the Senate. Meanwhile, his impeachment trial is starting, and we’re all on Twitter for a front-row seat.
Article Source: STAT
Seizure drug offers hope of expanding the pool of donor hearts
The moment a donor heart is cut off from its blood supply, transplant teams are on a race against the clock to remove it, transport it, and sew it into the recipient, all within four hours.
Covid vaccines didn’t work for many cancer patients — but researchers are designing a new shot for them
A couple months before the pandemic started, Joseph Ford started experiencing a rash of pinpoint polka dots around his lips, ankles, and lower legs.
Public health experts sketch a roadmap to get from the Covid pandemic to the ‘next normal’
A new report released Monday charts a path for the transition out of the Covid-19 pandemic, one that outlines both how the country can deal with the challenge of endemic Covid disease and how to prepare for future biosecurity threats.
By altering the blood type of lungs, researchers raise the possibility of universal organs for transplants
Her blood type, B positive, wasn’t a match for many donor organs, and a mismatched transplant would be catastrophic and deadly. But new research suggests this barrier could disappear if donor organs were treated with special enzymes that make them compatible with recipients of any blood type.
Early data indicate vaccines still protect against Omicron’s sister variant, BA.2
New data show that vaccines still protect against a spinoff of the Omicron variant, a welcome sign as the world keeps a close eye on the latest coronavirus iteration.
Researchers shatter the speed record for diagnosing rare genetic diseases with DNA sequencing
About a year ago, Matthew Kunzman’s heart was failing, despite doctors’ best attempts to bolster it with every pump and gadget they could think of. But the 14-year-old has bounced back in large part due to super-speedy genetic sequencing that pinpointed the cause of his disease and helped doctors decide how to treat it — in just 11 and a half hours.
As a Logic song topped the charts, helpline saw more calls and fewer suicides
During the time that a song whose title is the number of a national suicide prevention helpline topped charts, calls to the helpline increased and suicides decreased, a new study shows.
A reason for optimism on Omicron: Our immune systems are not blank slates
The emergence of a new Covid-19 variant with a startlingly large constellation of mutations has countries around the world sounding alarms.
HHMI philanthropy devotes $2 billion to boost inclusion and equity in biomedical sciences
Saying bold steps are needed to improve racial, ethnic, and gender diversity in science, the influential Howard Hughes Medical Institute on Thursday announced a $2 billion plan to accelerate inclusion and equity efforts throughout the academic science pipeline.
Watch: Merck’s Covid pill could transform treatment. Here’s how it works
Earlier this month, study results showed that molnupiravir, Merck’s investigational antiviral pill, cut hospitalization rates of Covid-19 patients by about half.
What we know — and don’t know — about Merck’s new Covid-19 pill
The announcement that a pill from Merck and partner Ridgeback Biotherapeutics kept Covid patients out of the hospital made headlines and moved stocks late last week. But as is so often true when data are released by press release, there are still many questions left unanswered.